AZ12799734（Cat No.:I022792）is an investigational small molecule being studied for its potential therapeutic applications, particularly in oncology and inflammation-related conditions. It is designed to target specific enzymes or signaling pathways that regulate cell growth, survival, and immune responses. By inhibiting these key molecular targets, AZ12799734 may help slow tumor progression, reduce inflammation, and enhance the effectiveness of existing treatments. Ongoing research is focused on evaluating its efficacy, safety, and potential in treating various cancers and autoimmune disorders. If successful, AZ12799734 could offer a new treatment option for patients with resistant or advanced diseases.